tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OGEN Stock Latest News

Oragenics, Inc. Announces Closing of Public Offering
Press ReleasesOragenics, Inc. Announces Closing of Public Offering
14d ago
OGEN
Oragenics to sell 8.1M shares at 55c in public offering
PremiumThe Fly
Oragenics to sell 8.1M shares at 55c in public offering
16d ago
OGEN
Oragenics, Inc. Announces Pricing of Public Offering
PremiumPress Releases
Oragenics, Inc. Announces Pricing of Public Offering
16d ago
OGEN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
21d ago
BCDA
MNKD
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
22d ago
CRMD
DRUG
Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients
PremiumPress ReleasesOragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients
30d ago
OGEN
Oragenics completes spray-dried formulation, filling in nasal device for ONP-002
Premium
The Fly
Oragenics completes spray-dried formulation, filling in nasal device for ONP-002
30d ago
OGEN
Oragenics files to sell 2.4M shares of common stock
Premium
The Fly
Oragenics files to sell 2.4M shares of common stock
1M ago
OGEN
Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards
PremiumPress Releases
Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards
1M ago
OGEN
Oragenics shows ONP-002 stable across wide temperature range
PremiumThe Fly
Oragenics shows ONP-002 stable across wide temperature range
1M ago
OGEN
Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range
PremiumPress Releases
Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range
1M ago
OGEN
Oragenics announces ONP-002 completes FDA-required Genotoxicity Study
PremiumThe Fly
Oragenics announces ONP-002 completes FDA-required Genotoxicity Study
1M ago
OGEN
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
PremiumPress ReleasesOragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
1M ago
OGEN
Oragenics announces concussion drug ONP-002 clears cardiotoxicity testing
Premium
The Fly
Oragenics announces concussion drug ONP-002 clears cardiotoxicity testing
1M ago
OGEN
Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing
Premium
Press Releases
Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing
1M ago
OGEN
Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
PremiumPress Releases
Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
2M ago
OGEN
Oragenics develops new formulation for novel neurosteroid
PremiumThe Fly
Oragenics develops new formulation for novel neurosteroid
2M ago
OGEN
Oragenics develops automated intranasal device for concussed patients
PremiumThe Fly
Oragenics develops automated intranasal device for concussed patients
3M ago
OGEN
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
PremiumPress Releases
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
3M ago
OGEN
Oragenics, Inc. Announces Closing of Public Offering
PremiumPress ReleasesOragenics, Inc. Announces Closing of Public Offering
3M ago
OGEN
Oragenics to sell 1.1M shares at $1.00 in public offering
Premium
The Fly
Oragenics to sell 1.1M shares at $1.00 in public offering
3M ago
OGEN
Oragenics, Inc. Announces Pricing of Public Offering
Premium
Press Releases
Oragenics, Inc. Announces Pricing of Public Offering
3M ago
OGEN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >